GLY-200
id:
gly-200-290-2831118
title:
GLY-200
text:
GLY-200 is an experimental drug that acts as a "polymeric mucin binding duodenal exclusion therapy"; it is developed by Glyscend Therapeutics for type 2 diabetes and obesity. It is intended to reversibly mimic the effects of gastric bypass without the need for surgery. The drug is not absorbed into the body from the gut and has been tested as monotherapy and with metformin.
brand slug:
wiki
category slug:
encyclopedia
description:
Pharmaceutical drug
original url:
https://en.wikipedia.org/wiki/GLY-200
date created:
date modified:
2024-01-31T15:00:22Z
main entity:
{"identifier":"Q123924937","url":"https://www.wikidata.org/entity/Q123924937"}
image:
fields total:
13
integrity:
14